Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Bairati

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Human Pathology|March 17, 2015
Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysisPatrice Desmeules, Dominique Trudel, Stéphane Turcotte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Prognostic significance of cyclooxygenase-2 overexpression in glottic cancerMelanie K Sackett, Isabelle Bairati, François Meyer, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|November 3, 2006
Implementing the role of patient-navigator nurse at a university hospital centreLise Fillion, Marie de Serres, Richard Lapointe-Goupil, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Genetic polymorphisms and head and neck cancer outcomes: a reviewJessica Hopkins, David W Cescon, Darren Tse, et al.
The British Journal of Nutrition|April 1, 2015
Dietary supplement use among cancer survivors of the NutriNet-Santé cohort studyCamille Pouchieu, Philippine Fassier, Nathalie Druesne-Pecollo, et al.
Gynecologic Oncology|August 31, 2013
A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancerDominique Trudel, David P Labbé, Monica Araya-Farias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2011
Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survivalAbul Kalam Azad, Isabelle Bairati, Elodie Samson, et al.
Cancer|October 20, 2011
Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancersAbul Kalam Azad, Isabelle Bairati, Elodie Samson, et al.
Pathology, Research and Practice|April 17, 2019
Proteases and their inhibitors as prognostic factors for high-grade serous ovarian cancerDominique Trudel, Luminita-Mihaela Avarvarei, Michèle Orain, et al.
Journal of the National Cancer Institute|April 7, 2005
A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patientsIsabelle Bairati, François Meyer, Michel Gélinas, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Human Pathology|March 17, 2015
Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysisPatrice Desmeules, Dominique Trudel, Stéphane Turcotte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Prognostic significance of cyclooxygenase-2 overexpression in glottic cancerMelanie K Sackett, Isabelle Bairati, François Meyer, et al.
Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique|November 3, 2006
Implementing the role of patient-navigator nurse at a university hospital centreLise Fillion, Marie de Serres, Richard Lapointe-Goupil, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Genetic polymorphisms and head and neck cancer outcomes: a reviewJessica Hopkins, David W Cescon, Darren Tse, et al.
The British Journal of Nutrition|April 1, 2015
Dietary supplement use among cancer survivors of the NutriNet-Santé cohort studyCamille Pouchieu, Philippine Fassier, Nathalie Druesne-Pecollo, et al.
Gynecologic Oncology|August 31, 2013
A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancerDominique Trudel, David P Labbé, Monica Araya-Farias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2011
Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survivalAbul Kalam Azad, Isabelle Bairati, Elodie Samson, et al.
Cancer|October 20, 2011
Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancersAbul Kalam Azad, Isabelle Bairati, Elodie Samson, et al.
Pathology, Research and Practice|April 17, 2019
Proteases and their inhibitors as prognostic factors for high-grade serous ovarian cancerDominique Trudel, Luminita-Mihaela Avarvarei, Michèle Orain, et al.
Journal of the National Cancer Institute|April 7, 2005
A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patientsIsabelle Bairati, François Meyer, Michel Gélinas, et al.
Pageof 6